2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Saturday, May 2, 2015

5:30pm-7:30pm: Impact of Anti-CMV Prophylactic Therapy on the Development of CMV Quantiferon Sero-Conversion in High-Risk Patients

A. Palanisamy, D. Taber, N. Pilch, C. Bratton, J. McGillicuddy, P. Baliga, K. Chavin.

Poster Session A: Late Breaking • Exhibit Hall E

5:30pm-7:30pm: Impact of Early Urinary Tract Infections on Renal Graft Function

J. Rago, L. Bowman, D. Brennan, J. Hagopain, T. Horwedel.

Poster Session A: Infection • Exhibit Hall E

5:30pm-7:30pm: Impact of HLA Antibody Monitoring After Kidney Transplantation

S. Rao,¹ M. Ghanta,¹ H. Parekh,² A. Gillespie,¹ I. Lee,¹ S. Geier,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ S. Constantinescu.¹

Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E

5:30pm-7:30pm: Impact of Pre-Transplant Panel Reactive Antibody Levels On Renal Graft Survival in Patients With Negative Cross-Match and No Donor Specific Antibody

K. Jun,¹ M. Kim,¹ H. Kim,¹ K. Park,² S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ S. Kim,¹ J. Kim,¹ I. Moon.¹

Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E

5:30pm-7:30pm: Impact of Proton Pomp Inhibitors on Hypomagnesemia and Arterial Stiffness in Renal Transplant Recipients

S. Sezer,¹ B. Gurlek Demirci,¹ M. Erkmen Uyar,¹ S. Uyanik,² M. Haberal.³

Poster Session A: Kidney: Cardiovascular and Metabolic • Exhibit Hall E

5:30pm-7:30pm: Impact of Sirolimus on the Risk of BK Viremia in Simultaneous Pancreas-Kidney Transplant Recipients

D. Wojciechowski, T. Yokoyama, S. Chandran, P. Stock.

Poster Session A: BK Virus Infection • Exhibit Hall E

5:30pm-7:30pm: Implications of Living Kidney Donor Histology, Volume and Function on Allograft Outcome

S. Shah,¹ B. Lankowsky,² L. Herlitz,³ A. Chiesa-Vottero,³ Z. Zaky,¹ D. Goldfarb,⁴ S. Flechner,⁴ E. Poggio.¹

Poster Session A: Delayed Function/Acute Injury/Outcomes/Glomerulonephritis • Exhibit Hall E

5:30pm-7:30pm: Improved Renal Function Post-Liver Transplant With Earlier Everolimus Conversion

S. Lin,¹ M. Zimmerman,² V. Lewis,¹ S. Biggins,³ C. Ruller,⁴ I. Kam,⁴ T. Nydam.⁴

Poster Session A: Liver: Immunosuppression and Rejection • Exhibit Hall E

5:30pm-7:30pm: Improving ABMR Diagnostics Through Advanced Anti-HLA Antibody Screening Techniques

R. Ponsirenas,^1,2 H. Cazarote,^1,2 S. Shimakura,³ J. Valdameri,¹ F. Contieri,⁴ C. von Glehn,^1,2 M. Susin.^1,2

Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E

5:30pm-7:30pm: Incidence and Impact of De Novo Donor-Specific Anti-HLA Antibodies in ABO-Compatible Liver-Transplant Recipients

A. Del Bello,^1,2 N. Congy-Jolivet,^2,3,4 D. Milongo,¹ C. Guilbeau-Frugier,^2,5 L. Lavayssière,¹ F. Muscari,^2,6 L. Rostaing,^1,2,7 N. Kamar.^1,2,7

Poster Session A: Liver: Immunosuppression and Rejection • Exhibit Hall E